We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks ‘New Paradigm’ on OTC Drug Switches, Wants Feedback
FDA Seeks ‘New Paradigm’ on OTC Drug Switches, Wants Feedback
March 2, 2012
The FDA will hold a two-day public hearing this month on the feasibility of switching certain drugs, traditionally only sold with a prescription, to OTC status with conditions of safe use — a move the agency calls a “new paradigm.”